Literature DB >> 1583731

Neutralization of influenza virus by low concentrations of hemagglutinin-specific polymeric immunoglobulin A inhibits viral fusion activity, but activation of the ribonucleoprotein is also inhibited.

S J Armstrong1, N J Dimmock.   

Abstract

High concentrations of hemagglutinin-specific neutralizing polymeric monoclonal immunoglobulin A (IgA) inhibit attachment of the majority of type A influenza virus virions to cell monolayers and tracheal epithelium (H. P. Taylor and N. J. Dimmock, J. Exp. Med. 161:198-209, 1985; M. C. Outlaw and N. J. Dimmock, J. Gen. Virol. 71:69-76, 1990). A minority of virions attaches but is not infectious. Here, we report that a different mechanism operates when influenza virus A/Puerto Rico/8/34 (H1N1) is neutralized by low concentrations of monoclonal polymeric IgA or when A/fowl plague virus/Rostock/34 (H7N1) is neutralized by low concentrations of polyclonal rat secretory IgA. Under these conditions, neutralized virus attaches to cells and is taken up by them. However, upon entering the cell, the nucleoprotein (NP) of neutralized virus is found in the perinuclear cytoplasm, whereas NP from nonneutralized virus is concentrated in the nucleus itself. Further data show that the low-pH-mediated cell fusion activity of virions is inhibited by IgA in proportion to loss of infectivity. The possibilities that neutralization by low amounts of polymeric IgA is caused by inhibition of the virion fusion activity and that the aberrant distribution of NP from neutralized virus results from its failure to escape from the endosomal system were investigated by using A/PR/8/34 and the fusogenic agent polyethylene glycol (PEG) at pH 5.4. A/PR/8/34 attached to cells at 4 degrees C, with minimal internalization of the virus; treatment with PEG at pH 5.4 and 4 degrees C for 1 min led to infectious fusion of nonneutralized virus with the plasma membrane and, under these conditions, was more efficient than PEG at pH 7 or medium at pH 5.4. Neutralized virus which was attached to cells and treated with acidified PEG appeared to undergo primary and secondary uncoating, with its NP protein becoming concentrated in the nucleus and M1 becoming concentrated in the perinuclear cytoplasm. Although the distribution of NP and M1 was indistinguishable from infectious virus, infectivity was not restored. Thus, even when IgA-induced inhibition of fusion is reversed, virus is still neutralized. We suggest that infectious influenza virus undergoes an activation stage which may be the relaxation of the ribonucleoprotein structure needed to permit transcription or may be the removal of M1 bound to the ribonucleoprotein.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1583731      PMCID: PMC241168     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Morphological studies of the neutralization of influenza virus by IgM.

Authors:  S J Armstrong; M C Outlaw; N J Dimmock
Journal:  J Gen Virol       Date:  1990-10       Impact factor: 3.891

2.  Isolation of matrix protein M1 from influenza viruses by acid-dependent extraction with nonionic detergent.

Authors:  O P Zhirnov
Journal:  Virology       Date:  1992-01       Impact factor: 3.616

3.  Monoclonal antibodies detect M-protein epitopes on the surface of influenza virions.

Authors:  L Joassin; C Vincenzotto; J M Cloes; M Bouchet; M Reginster
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

4.  Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds.

Authors:  L J Holsinger; R A Lamb
Journal:  Virology       Date:  1991-07       Impact factor: 3.616

5.  Electron microscopy of human and mouse myeloma serum IgA.

Authors:  R R Dourmashkin; G Virella; R M Parkhouse
Journal:  J Mol Biol       Date:  1971-02-28       Impact factor: 5.469

6.  Electron microscopy of the influenza virus submembranal structure.

Authors:  R W Ruigrok; L J Calder; S A Wharton
Journal:  Virology       Date:  1989-11       Impact factor: 3.616

7.  Electron microscopic evidence for the association of M2 protein with the influenza virion.

Authors:  D C Jackson; X L Tang; K G Murti; R G Webster; G W Tregear; W J Bean
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

8.  Amantadine inhibits an early, M2 protein-dependent event in the replication cycle of avian influenza (H7) viruses.

Authors:  A P Kendal; H D Klenk
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

9.  Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions.

Authors:  S L Zebedee; R A Lamb
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

10.  Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel.

Authors:  R J Sugrue; A J Hay
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

View more
  17 in total

1.  Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event.

Authors:  M J Edwards; N J Dimmock
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

2.  Multiple functions of immunoglobulin A in mucosal defense against viruses: an in vitro measles virus model.

Authors:  Huimin Yan; Michael E Lamm; Ewa Björling; Yung T Huang
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens.

Authors:  A Bacon; J Makin; P J Sizer; I Jabbal-Gill; M Hinchcliffe; L Illum; S Chatfield; M Roberts
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Secretory IgA in saliva can be a useful stress marker.

Authors:  S Tsujita; K Morimoto
Journal:  Environ Health Prev Med       Date:  1999-04       Impact factor: 3.674

Review 5.  Is there a role for a mucosal influenza vaccine in the elderly?

Authors:  E M Corrigan; R L Clancy
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

6.  Isotype-specific antibody responses to foot-and-mouth disease virus in sera and secretions of "carrier' and "non-carrier' cattle.

Authors:  J S Salt; G Mulcahy; R P Kitching
Journal:  Epidemiol Infect       Date:  1996-10       Impact factor: 2.451

7.  Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies.

Authors:  M B Mazanec; C L Coudret; D R Fletcher
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

8.  Protective antibodies inhibit reovirus internalization and uncoating by intracellular proteases.

Authors:  H W Virgin; M A Mann; K L Tyler
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

Review 9.  Intranasal cold-adapted influenza virus vaccine combined with inactivated influenza virus vaccines: an extra boost for the elderly?

Authors:  Paul V Targonski; Gregory A Poland
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

10.  Neutralization of Virus Infectivity by Antibodies: Old Problems in New Perspectives.

Authors:  P J Klasse
Journal:  Adv Biol       Date:  2014-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.